"See How This Hospital Uses Artificial Intelligence To Find Kidney Disease" - Jennifer Kite-Powell
The role of artificial intelligence (AI) in healthcare continues to rise. Mount Sinai Hospital announced a partnership with the AI healthcare startup, RenalytixAI, to create an AI tool that identifies patients at the hospital who are at risk for advanced kidney disease. Mount Sinai and RenalytixAI will put more than 3 million patient health records into the AI tool to identify at-risk patients. “This venture is bringing the promise of personalized medicine and population health to fruition," said Barbara Murphy, MD, dean of clinical integration and population health and chair of the department of medicine at the Icahn School of Medicine at Mount Sinai, and chair of the RenalytixAI Scientific Advisory board.
- Barbara Murphy, MD, Dean, Clinical Integration and Population Health, Chair, Department of Medicine, Icahn School of Medicine at Mount Sinai
- Erik Lium, PhD, Senior Vice President, Mount Sinai Innovation Partners